Compare
Johnson & Johnson vs Liquidia (JNJ vs LQDA)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Johnson & Johnson (JNJ) returned +48.5% and Liquidia (LQDA) +68.0%; so far this year the figures are +33.5% and +28.7%.
Johnson & Johnson is the larger company by market value, about 167.5 times the size of Liquidia.
On trailing earnings, JNJ trades at 41.9 times and LQDA at 31.9 times.
Revenue grew +7.8% at JNJ and +2233.6% at LQDA over the last year.
JNJ yields 1.91%. LQDA pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| JNJ | LQDA | |
|---|---|---|
| Price | $276.22 | $44.40 |
| 1-day | +1.43% | -0.20% |
| YTD | +33.47% | +28.73% |
| 1 year | +48.51% | +68.05% |
| 3 years | +85.77% | +573.75% |
| Market cap | $665.0B | $4.0B |
| P/E | 41.9 | 31.9 |
| P/S | 6.69 | 8.81 |
| P/B | 8.16 | 20.37 |
| Revenue growth | +7.80% | +2233.60% |
| EPS growth | -36.40% | — |
| Gross margin % | 67.6 | 1.8 |
| Net margin % | 16.2 | 30.7 |
| ROE % | 19.7 | 71.0 |
| Debt / equity | 0.55 | 0.10 |
| FCF yield % | 3.1 | 3.8 |
| Dividend yield % | 1.91 | — |
| Beta | -0.09 | 0.91 |
| RSI (14) | 59.4 | 51.0 |
| Technical rating |